• 25 SEP 18
    • 0

    Radiation Oncology May Head Toward Personalization

    Radiation therapy is one of the safest, most effective and most useful treatments for cancer, with up to 80 percent of all cancer patients receiving radiation of some kind as part of their treatment. In fact, radiotherapy is not only used to cure or relieve symptoms of cancer, but also to make other treatments such as surgery and chemotherapy more effective. Because of its immense value in oncology, radiotherapy currently is being considered for use with several other treatments like immunotherapy to create more effective therapies with better treatment outcomes for patients.

    “Radiation can still do more in cancer treatment than what’s typically thought, particularly when it’s combined with advanced immunotherapy techniques,” said Dr. Steven E. Finkelstein, director at Bay Regional Cancer Center, Panama City. “For instance, ablative therapy is able to cure oligoprogressive and oligometastatic cancer by combining radiation with immunotherapy techniques. Likewise, the ability of radiation to offer better local control and systemic benefits with oligometastatic disease shows that a blend of immunotherapy and radiotherapy offers more promise for better cancer treatment outcomes.”

    Taking Advantage of Patient Hemobiology

    But for such a combination of radiotherapy and immunotherapy to work, it should be designed by taking into account a patient’s hemobiology. Investigations on potent radiotherapy and immunotherapy treatments should go beyond just genetically targeted therapeutic innovations if they are to have a greater impact on cancer therapy.

    “In the era of precision medicine, measuring a patient’s sensitivity or resistance to radiation therapy can offer valuable insights into appropriate radiation dosage and the most effective ways to deliver radiation,” said Dr. Finkelstein. “So as we continue to implement a mix of immunotherapy, radiotherapy and precision medicine techniques, we must be committed to tailoring every treatment to each patient’s specific tumor biology in order to achieve better outcomes.”

    Better Patient Targeting

    New genomic and imaging approaches are promising to make individualized radiotherapy and immunotherapy treatments a success by making it easier to select the right patients to undergo various procedures. This in turn helps to optimize the benefit-to-risk ratio of treatments.

    “By exploiting advanced imaging and genomic techniques now available to us, we are able to choose the right combination of treatments for our patients,” said Dr. Finkelstein. “As a result, we are now able to design more personalized, safer and highly effective treatments, ensuring that every patient gets the best possible care.”

    At Bay Regional Cancer Center, we have an assortment of the latest radiotherapy and immunotherapy equipment and technology to help us take advantage of these advances when designing your treatment. And by relying on the huge pool of medical professionals at Advanced Urology Institute through our collaborative, multidisciplinary approach to care, we ensure that your treatment is delivered with utmost precision and accuracy, and offers maximum safety and efficacy. Looking for cancer care that is tailored for your specific care needs? Visit the “Bay-Regional-Cancer Center” site.

Comments